Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations Meeting Abstract


Authors: Janjigian, Y. Y.; Park, B. J.; Kris, M. G.; Miller, V. A.; Riely, G. J.; Zheng, J.; Dycoco, J. P.; Shen, R.; Azzoli, C. G.
Abstract Title: Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations
Meeting Title: 45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 27
Issue: 15 Suppl.
Meeting Dates: 2009 May 29-Jun 2
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2009-05-20
Start Page: 387s
Language: English
ACCESSION: WOS:000276606605124
PROVIDER: wos
Notes: Meeting Abstract: 7523 -- Source: Wos
MSK Authors
  1. Junting Zheng
    130 Zheng
  2. Christopher G Azzoli
    105 Azzoli
  3. Ronglai Shen
    127 Shen
  4. Vincent Miller
    261 Miller
  5. Yelena Yuriy Janjigian
    145 Janjigian
  6. Gregory J Riely
    344 Riely
  7. Bernard J Park
    155 Park
  8. Joseph Dycoco
    22 Dycoco
  9. Mark Kris
    597 Kris